However, in addition to the cell proliferation end-point, PEITC also had no effect on PSA expression in LNCaP prostate tumors (Fig. 5B and C), corroborating the lack of PEITC effects on androgen-mediated pathways in vitro (Fig. 5A). The gene discussed is KLK3; the disease is prostate neoplasm.